Garda Capital Partners LP Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001666905

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2025 · 11 positions · Total reported value $23.12M · Top-10 concentration 99.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 90.9% · 2 new · 1 cut · 7 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.8% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): +2.1% · vs SPY +0.0% · Prev Value $168.23M — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2025 13F filing, Garda Capital Partners LP disclosed 11 equity positions with a combined reported value of $23.12M. The filing implies a focused portfolio: its ten largest positions account for 99.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2025 were MRNA ($7.75M), ZIM ($5.42M), FSLR ($4.41M). By sector, the heaviest allocations are Health Care 37.8%, Consumer Discretionary 26.3%. Versus the prior quarter, allocation shifted toward Health Care (+33.2pp), Consumer Discretionary (+13.7pp) and away from Energy (-3.9pp), Utilities (-5.5pp).

Versus the prior quarter, Garda Capital Partners LP opened 2 new positions, trimmed 1 and fully exited 7, a turnover rate of 90.9% of positions. The portfolio's overlap with the prior quarter was 5% of names.

The largest new positions opened in Q3 2025 were FSLR ($4.41M).

Of the 7 positions fully exited versus the prior quarter, the largest were MSFT ($51.53M), AMD ($41.72M), SPY ($32.62M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2025)

  • FSLR FIRST SOLAR INC · $4.41M

Fully Exited (vs previous quarter)

  • MSFT MICROSOFT CORP · prev qtr: $51.53M
  • AMD ADVANCED MICRO DEVICES INC · prev qtr: $41.72M
  • SPY STATE STR SPDR S&P 500 ETF T · prev qtr: $32.62M
  • PRKA BANK AMERICA CORP · prev qtr: $25.27M
  • GDX VANECK ETF TRUST · prev qtr: $25.27M
  • TSLA TESLA INC · prev qtr: $24.62M
  • INTU INTUIT · prev qtr: $20.32M
  • LRCX LAM RESEARCH · prev qtr: $18.56M

Insider Transactions (Form 4)

Latest Garda Capital Partners LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Garda Capital Partners LP is an alternative investment management firm founded by Chris Cole and headquartered in Wayzata, Minnesota, specializing in tail risk hedging strategies to protect against extreme market events.

Investment Approach

Focuses on identifying and protecting against extreme market events and tail risks

Utilizes sophisticated quantitative models and derivative strategies

Emphasizes capital preservation during market stress periods

Asset Classes & Strategy

Manages diverse portfolio including equities, derivatives, and alternative investments

Specializes in volatility and tail risk strategies

Employs both long and short positions across various asset classes

Key Personnel

Chris Cole: Founder and portfolio manager, known for expertise in tail risk strategies

Additional team members with backgrounds in quantitative finance and risk management

Firm Overview

Manages approximately $207.1 billion in assets under management

Files SEC Form 13F, indicating significant US equity positions

Established as a leader in alternative investment strategies

This profile is based on publicly available information; please refer to official SEC filings for the most current and complete disclosures.

Sector Allocation

Health Care 37.8%
Technology 22.7%
Financials 2.2%
Utilities 1.2%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 300.00K $7.75M 33.52%
33.52%
Hold
2 400.00K $5.42M 23.44%
23.44%
Hold
3 20.00K $4.41M 19.08%
19.08%
New
4 1.70K $2.09M 9.03%
9.03%
Reduce
5 5.50K $829.35K 3.59%
3.59%
Add
6 2.90K $717.58K 3.10%
3.10%
Reduce
7 28.50K $665.19K 2.88%
2.88%
Reduce
8 11.50K $512.33K 2.22%
2.22%
Hold
9 14.60K $281.34K 1.22%
1.22%
Reduce
10 3.00K $269.94K 1.17%
1.17%
Reduce
11 19.00K $177.46K 0.77%
0.77%
Hold

FAQ

What did Garda Capital Partners LP buy in 2025-Q3?

In its 2025-Q3 13F filing, Garda Capital Partners LP reported 11 equity positions worth $23.12M in aggregate; its largest disclosed positions were MRNA ($7.75M), ZIM ($5.42M), FSLR ($4.41M).

How large is Garda Capital Partners LP's portfolio?

Garda Capital Partners LP reported $23.12M of long equity holdings across 11 positions as of 2025-Q3. Top-10 holdings account for 99.2% of reported value.

What is Garda Capital Partners LP's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/garda-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →